Clover Health Investments Stock Performance
| CLOV Stock | USD 2.91 0.12 3.96% |
Clover Health holds a performance score of 18 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.34, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Clover Health will likely underperform. Use Clover Health maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Clover Health.
Risk-Adjusted Performance
18 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Clover Health Investments are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Clover Health showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.96) | Five Day Return (5.83) | Year To Date Return 203.19 | Ten Year Return (71.47) | All Time Return (71.47) |
1 | Disposition of 137108 shares by Sharp Aric R of Clover Health at 1.23 subject to Rule 16b-3 | 06/28/2024 |
2 | Disposition of 308341 shares by Andrew Toy of Clover Health at 1.2 subject to Rule 16b-3 | 07/01/2024 |
3 | Disposition of 5388 shares by Jamie Reynoso of Clover Health at 1.25 subject to Rule 16b-3 | 07/03/2024 |
4 | Clover Health Investments to Release Quarterly Earnings on Monday - MarketBeat | 07/29/2024 |
5 | Clover Health Investments Second Quarter 2024 Earnings Beats Expectations | 08/07/2024 |
6 | Clover Health Investments Is Attractively Priced Despite Fast-paced Momentum | 08/08/2024 |
7 | Disposition of 6968 shares by Sharp Aric R of Clover Health at 1.86 subject to Rule 16b-3 | 08/09/2024 |
8 | Clover Health Investments, Corp. Surges 32 percent Yet Its Low PS Is No Reason For Excitement | 08/14/2024 |
9 | Disposition of tradable shares by Tran Thomas L of Clover Health subject to Rule 16b-3 | 08/20/2024 |
10 | Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference | 08/21/2024 |
11 | Despite Fast-paced Momentum, Clover Health Investments Is Still a Bargain Stock | 08/27/2024 |
12 | The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest | 09/03/2024 |
13 | Zacks Industry Outlook Highlights Medical Systems, Clover Health Investments and CareCloud | 09/05/2024 |
14 | Why Fast-paced Mover Clover Health Investments Is a Great Choice for Value Investors | 09/12/2024 |
15 | Disposition of 8691 shares by Jamie Reynoso of Clover Health at 2.99 subject to Rule 16b-3 | 09/13/2024 |
| Begin Period Cash Flow | 186.2 M |
Clover |
Clover Health Relative Risk vs. Return Landscape
If you would invest 131.00 in Clover Health Investments on June 25, 2024 and sell it today you would earn a total of 160.00 from holding Clover Health Investments or generate 122.14% return on investment over 90 days. Clover Health Investments is currently generating 1.46% in daily expected returns and assumes 6.2927% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of stocks are less volatile than Clover, and 71% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Clover Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clover Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Clover Health Investments, and traders can use it to determine the average amount a Clover Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.232
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CLOV | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.29 actual daily | 55 55% of assets are less volatile |
Expected Return
| 1.46 actual daily | 29 71% of assets have higher returns |
Risk-Adjusted Return
| 0.23 actual daily | 18 82% of assets perform better |
Based on monthly moving average Clover Health is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clover Health by adding it to a well-diversified portfolio.
Clover Health Fundamentals Growth
Clover Stock prices reflect investors' perceptions of the future prospects and financial health of Clover Health, and Clover Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clover Stock performance.
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.065 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 1.07 B | ||||
| Shares Outstanding | 407.82 M | ||||
| Price To Book | 4.46 X | ||||
| Price To Sales | 0.69 X | ||||
| Revenue | 2.03 B | ||||
| Gross Profit | 126.19 M | ||||
| EBITDA | (180.16 M) | ||||
| Net Income | (213.36 M) | ||||
| Cash And Equivalents | 711.78 M | ||||
| Cash Per Share | 1.49 X | ||||
| Total Debt | 4.66 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 0.66 X | ||||
| Cash Flow From Operations | (115.87 M) | ||||
| Earnings Per Share | (0.24) X | ||||
| Market Capitalization | 1.45 B | ||||
| Total Asset | 570.67 M | ||||
| Retained Earnings | (2.16 B) | ||||
| Working Capital | 166.85 M | ||||
About Clover Health Performance
Evaluating Clover Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Clover Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Clover Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 14.39 | 15.11 | |
| Return On Tangible Assets | (0.38) | (0.36) | |
| Return On Capital Employed | (0.67) | (0.64) | |
| Return On Assets | (0.37) | (0.39) | |
| Return On Equity | (0.74) | (0.71) |
Things to note about Clover Health Investments performance evaluation
Checking the ongoing alerts about Clover Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Clover Health Investments help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Clover Health is way too risky over 90 days horizon | |
| Clover Health appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 2.03 B. Net Loss for the year was (213.36 M) with profit before overhead, payroll, taxes, and interest of 126.19 M. | |
| Clover Health Investments currently holds about 711.78 M in cash with (115.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.49. | |
| Clover Health has a poor financial position based on the latest SEC disclosures | |
| Latest headline from zacks.com: Why Fast-paced Mover Clover Health Investments Is a Great Choice for Value Investors |
- Analyzing Clover Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clover Health's stock is overvalued or undervalued compared to its peers.
- Examining Clover Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Clover Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clover Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Clover Health's stock. These opinions can provide insight into Clover Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Clover Stock Analysis
When running Clover Health's price analysis, check to measure Clover Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clover Health is operating at the current time. Most of Clover Health's value examination focuses on studying past and present price action to predict the probability of Clover Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clover Health's price. Additionally, you may evaluate how the addition of Clover Health to your portfolios can decrease your overall portfolio volatility.